Navigation Links
list in Medical Technology

Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

... of CYP3A in patients receiving PREZISTA/r. This list of potential drug interactions is not complete. ... dyspepsia (2 percent). This is not a complete list of all adverse drug reactions reported with the ... toward health care cost containment. A further list and description of these risks, uncertainties and ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... and abnormal movements of the eyes. This is not a complete list of all possible side effects. Ask your doctor or treatment team if you ... and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be ...

Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences

... guidelines issued by the U.S. Department of Health and Human Services list emtricitabine and tenofovir (the components of Truvada) in combination ... regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be ...

Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction

... ability to protect our intellectual property, our ability to continue to list our common stock on the NASDAQ Global Market or to list our common stock on the NASDAQ Capital Market and those other factors ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... of the leaders, and they will pursue the following important topics (full list of team members can be found at www.su2c.org ): ... charitable organization for the television and film businesses. [A full list of SAC members can be found at www.su2c.org.] SU2C As a Movement ...

CareHere's Electronic Medication System Proves 100 Percent Effective in Response to Recall

... medication tracking system allowed the company to instantly generate a list of all patients taking the medication. Fortunately, 100 percent of the ... that patients fill at off-site pharmacies. The third function stores a list of all current medications and those previously prescribed by CareHere and ...

Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange

... and new product introductions on our overall profitability. A further list and description of these risks, uncertainties and other matters can be ... on April 17, 2007. Impact Medical Solutions cautions that the foregoing list of important factors is not complete and assumes no obligation to update ...

Impact Medical Solutions Announces Appointment of New Director and Corporate Update

... and new product introductions on our overall profitability. A further list and description of these risks, uncertainties and other matters can be ... on April 17, 2007. Impact Medical Solutions cautions that the foregoing list of important factors is not complete and assumes no obligation to update ...

SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver

... SROs across the United States and even globally." For a complete list of participating physicians and centers, as well as a list of trials that are in progress, please visit http://www.SpineMarkSRO.com ....

New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy

... of INTELENCE or the co-administered drug(s). This is not a complete list of potential drug interactions Please see full Prescribing ... and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be ...

European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)

... in March 2007, the World Health Organization added ATRIPLA to its Model list of Essential Medicines. Important Product Safety Information About ... adverse events. See Full Prescribing Information for complete list of drug-drug interactions. In Study 934, the most frequently reported ...

New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy

... inhibitors, or inducers of CYP3A in patients receiving PREZISTA/r. This list of potential drug interactions is not complete. PREZISTA must be ... and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be ...

EpiCept Reports Regulatory Progress on Ceplene(TM)

... Specifically, EpiCept submitted full responses to the Day 120 Consolidated list of Questions. EpiCept's staff and expert consultants met on September 17 ... milestone on Ceplene's path to approval is expected to be the CHMP Day 180 list of outstanding issues, which EpiCept expects will be received in the ...

Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline

... Which are the Ones-to-Watch this Quarter? Topping this quarter's approval list is Novartis Vaccines & Diagnostics' Optaflu(R), a vaccine for influenza ... Novartis plans to file for US approval of Optaflu in 2008. Second on our list is Wyeth, which is marketing Lybrel(TM) -- a combination of Levonorgestrel ...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

... and reducing costs for a wide range of public and private sector clients, and 2008 revenue exceeding $51 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. For more information, go to ...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

... product suites; and general economic conditions such as the rate of employment, inflation, interest rates and the condition of capital markets. This list of factors is not all-inclusive. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of ...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

... of stem cell preservation obsolete; and any other risk factors described in our filing with the Securities and Exchange Commission. The foregoing list is not exhaustive, and the Company disclaims any obligations to subsequently revise any forward-looking statements to reflect events or circumstances ...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

... lawsuits, investigations or other proceedings resulting from our September 2007 settlement with the U.S. government and other matters. For a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim ...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for ...

SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts

... Hospital, Mount Sinai Hospital, the State University of New York , the University of Maryland , Drexel University , and the NCAA. A full list of panelists is attached. About SUNY Youth Sports: The SUNY Youth Sports Institute training network is called Youth Sports NY . It works with ...

MADIT-CRT Trial Meets Primary Endpoint

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in ...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

... take their prescription drugs properly," notes HCPC Executive Director Peter G. Mayberry. "And one reason that is almost always on the top of the list is 'forgetfulness.'" A recent study funded by the U.S. Department of Health and Human Services concludes, however, that better pharmaceutical ...

Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009

... development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for ...

New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform

... and improve quality of life" than the statement "we should invest in prevention to lower health care costs" (21 percent). "We gave Americans a list of proposals being considered to reform health care, and investing in prevention trumped them all," said Bill McInturff, Partner and Co-Founder of ...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

... Physicians from one group received a fax from the pharmacy that outlined clinical guidelines from the American Diabetes Association and provided a list of available medications available in the category and a prescription form pre-populated with the patient's information. Twenty-one percent of ...

WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center

... Center. Once at the hospital, they met the transplant team and learned about the road ahead. They discussed all of their options, transplant list as well as the Living Donor Institute. Jim was excited about the Living Donor Institute option where individuals interested in donating a kidney, ...

Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons

... IL. The meeting presents approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research and technology. A list of all scientific presentations related to radiofrequency ablation for Barrett's esophagus can be found at www.barrx.com ...

Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology

... identified in the Company's Annual Report/Form 20-F for 2008. Nothing contained herein should be construed as a profit forecast. Reference list (1) Herbst, R. et al. Vandetanib plus docetaxel vs docetaxel as 2nd-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): ...

Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in ...

Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our ...

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

... reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants annually, but less than 3,000 will receive a transplant each year. A large number of people who suffer ...

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in ...

New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in ...

Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in ...

Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our ...

Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting

... approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for ...

Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine

... and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in ...
Other Contents
(Date:8/20/2015)... The wearable technology market has traditionally ... healthy. However, wearable technology has the potential to ... improve diagnostic capabilities and therapeutic outcomes. Today, Leaf ... Technologies Conference 2015 , where Barrett Larson ... healthcare.    "Over the past decade, ...
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... it has joined The Smart Card Alliance and the ... Card Alliance and the Smart Card Alliance Latin America ... to industry peers and thought leaders promoting adoption of ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas today ... contributor to the Submission Content Management webinar ... a non-profit forum. Dedicated to the Implementation of ... neutral platform for industry, vendors, health authorities, ... and work towards a standard method of ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
(Date:9/3/2015)... ... September 03, 2015 , ... ... a privately held medical technology company that will bring low-cost cancer pre-screening tests ... , Preora’s proprietary and automated technology platform detects and measures cellular changes ...
(Date:9/3/2015)... ... September 03, 2015 , ... Mayo School ... have chosen Center for Hospice Care (CHC) for physician Hospice and Palliative ... CHC as part of fulfilling their requirements for obtaining national Board Certification in ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... Real ... products, today announced that professional bull rider David Mason has signed an official endorsement ... calf at the age of six and his first bull at 15. He is ...
(Date:9/3/2015)... ... 03, 2015 , ... Today, Splashtop announced availability of its ... of the LANDESK One Partner program. Splashtop remote desktop solutions complement ... experience in remote access and control:, , LANDESK customers ...
(Date:9/3/2015)... ... ... The Linda Hall Library 2015 Fall Lecture Series will give ... at the South Pole, and the interior of life-extending stem cells – educating ... foremost independently funded research library devoted to science, engineering, and technology, will feature the ...
Breaking Medicine News(10 mins):Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Physicians from Mayo Clinic and Indiana University to Complete Hospice & Palliative Medicine Training at Center for Hospice Care 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5
Other TagsOther Tags